Prevention · Screening · Early detection

Breast Cancer Screening

Mammography can find breast cancer before a lump is felt. Organisations recommend different schedules because they weigh benefits and harms differently.

Chapter 8 of 16

8 of 16
Choose a chapter

Key facts

  • A new lump needs assessment at any age.
  • Ultrasound usually complements rather than replaces mammography.
  • Inherited risk or prior chest radiotherapy may require specialist screening.

Recommendations at a glance

These are guideline comparisons, not a personalised prescription. Symptoms and high-risk history take priority over routine screening schedules.

Eligibility, timing and limitations
Guideline / groupAge or eligibilityTest / intervalImportant limitation
USPSTF 202440–74Mammography every 2 years75+: evidence insufficient; individual discussion
ACS40–44 optional; 45–54 annual; 55+Annual or every 2 years from 55Continue in good health with at least 10 years expected remaining life
High inherited riskIndividual, often earlierMRI plus mammography under specialist careDo not use an average-risk schedule

Choose the right next step

  1. New or concerning symptoms? Arrange diagnostic assessment. Severe bleeding, breathlessness or new neurological weakness needs urgent care.
  2. No symptoms, but previous cancer, precancer or increased inherited risk? Ask for an individual surveillance plan; average-risk intervals may not apply.
  3. No such history? Use this chapter to discuss prevention and, where appropriate, age- and test-specific screening. Lifestyle exposures alone do not establish eligibility for every test.
  4. After testing: Collect the result, complete any referral, and record the next review date. A normal screen does not explain a later symptom.

Risk and the available tests

Age, family history, some inherited gene variants, breast density and previous chest irradiation can affect risk. Mammography uses low-dose X-rays; digital breast tomosynthesis creates layered images and is an accepted mammographic technique. Ultrasound can assess a lump or selected additional findings. MRI is more sensitive in some high-risk settings but can produce additional false positives and usually requires contrast.

Average-risk recommendations differ

USPSTF 2024 recommends mammography every two years at 40–74 (grade B), with insufficient evidence to determine the balance at 75 or older. ACS offers the option of annual screening at 40–44, recommends annual mammography at 45–54, and annual or biennial screening from 55 while in good health with an expected remaining lifespan of at least ten years. These recommendations are not interchangeable: discuss annual versus biennial screening and the balance of benefit and false alarms.

High-risk screening is individualised

ACS describes annual MRI plus mammography, usually from around 30, for defined high-risk groups such as BRCA-related risk or an estimated lifetime risk around 20–25% or more. Gene-specific protocols can start MRI earlier. Prior chest irradiation at a young age needs a plan based on age at exposure and elapsed time. MRI does not automatically replace mammography, and a generic online score should not determine the plan.

Breast density and false alarms

Dense tissue can make mammograms harder to interpret and is itself a risk factor. Additional ultrasound or MRI may find cancers but also create recalls and benign biopsies. USPSTF considers evidence insufficient for universal supplemental screening solely for density after a negative mammogram. Ask about your overall risk rather than assuming density always requires MRI.

Indian programme versus mammography guidance

The Indian operational framework uses clinical breast examination for eligible women in the 30–65 programme group, historically every five years, with referral for abnormal findings. ACS, in contrast, does not recommend clinical breast examination as routine screening for average-risk women. This difference reflects different programme settings; it does not remove the need for examination of a symptom. The Indian framework is not a national mammography mandate starting at 40. Local services and specialist advice may differ. International guideline ages should be discussed in the context of access to quality imaging and follow-up.

Symptoms, awareness and next steps

Know your usual breast appearance and feel without assuming a rigid monthly self-examination prevents cancer deaths. A new lump, nipple inversion, bloody discharge, skin dimpling or unexplained swelling needs evaluation. Diagnostic imaging and biopsy may be needed even after a recent normal screening mammogram. Bring previous images to reduce unnecessary repeats.

Practical steps

  • Ask whether your family or treatment history puts you in a high-risk group.
  • Discuss the schedule you choose and document the next date.
  • Attend recall appointments; most recalls do not prove cancer.

Myth and fact

A normal mammogram means a new lump can be ignored.

False. A persistent new lump requires clinical assessment.

Frequently asked questions

Is ultrasound enough for routine screening?

Usually it is not a substitute for recommended mammography; its role depends on the clinical question.

Should everyone have an MRI?

No. MRI is mainly for selected risk groups or diagnostic questions and has costs and false-positive harms.

Continue learning

Sources and guideline context